196 related articles for article (PubMed ID: 35053335)
21. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
Dmitriev OY
Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266
[TBL] [Abstract][Full Text] [Related]
22. A systems biology approach reveals new endoplasmic reticulum-associated targets for the correction of the ATP7B mutant causing Wilson disease.
Concilli M; Iacobacci S; Chesi G; Carissimo A; Polishchuk R
Metallomics; 2016 Sep; 8(9):920-930. PubMed ID: 27714068
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
24. The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.
Zhang Z; Wang H; Ding Q; Xing Y; Xu D; Xu Z; Zhou T; Qian B; Ji C; Pan X; Zhong A; Ying Z; Zhou C; Shi M
Biomed Pharmacother; 2017 May; 89():1055-1060. PubMed ID: 28292013
[TBL] [Abstract][Full Text] [Related]
25. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.
Wang S; Ni HM; Chao X; Wang H; Bridges B; Kumer S; Schmitt T; Mareninova O; Gukovskaya A; De Lisle RC; Ballabio A; Pacher P; Ding WX
Autophagy; 2019 Nov; 15(11):1954-1969. PubMed ID: 30894069
[TBL] [Abstract][Full Text] [Related]
26. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
27. TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study.
Bertozzi S; Londero AP; Viola L; Orsaria M; Bulfoni M; Marzinotto S; Corradetti B; Baccarani U; Cesselli D; Cedolini C; Mariuzzi L
BMC Cancer; 2021 Oct; 21(1):1118. PubMed ID: 34663249
[TBL] [Abstract][Full Text] [Related]
28. ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl.
Xu W; Cai B; Chen JL; Li LX; Zhang JR; Sun YY; Wan XP
Int J Gynecol Cancer; 2008; 18(4):718-22. PubMed ID: 17944925
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells.
Parisi S; Polishchuk EV; Allocca S; Ciano M; Musto A; Gallo M; Perone L; Ranucci G; Iorio R; Polishchuk RS; Bonatti S
Sci Rep; 2018 Apr; 8(1):6247. PubMed ID: 29674751
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells.
Fang LM; Li B; Guan JJ; Xu HD; Shen GH; Gao QG; Qin ZH
Acta Pharmacol Sin; 2017 Sep; 38(9):1305-1316. PubMed ID: 28603284
[TBL] [Abstract][Full Text] [Related]
31. Bafilomycin A1 increases the sensitivity of tongue squamous cell carcinoma cells to cisplatin by inhibiting the lysosomal uptake of platinum ions but not autophagy.
Chu HY; Wang W; Chen X; Jiang YE; Cheng R; Qi X; Zhong ZM; Zeng MS; Zhu XF; Sun CZ
Cancer Lett; 2018 Jun; 423():105-112. PubMed ID: 29524554
[TBL] [Abstract][Full Text] [Related]
32. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.
Safaei R; Howell SB
Crit Rev Oncol Hematol; 2005 Jan; 53(1):13-23. PubMed ID: 15607932
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB
Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138
[TBL] [Abstract][Full Text] [Related]
34. Copper-independent lysosomal localisation of the Wilson disease protein ATP7B.
Maji S; Pirozzi M; Ruturaj ; Pandey R; Ghosh T; Das S; Gupta A
Traffic; 2023 Dec; 24(12):587-609. PubMed ID: 37846526
[TBL] [Abstract][Full Text] [Related]
35. MTF1 binds to metal-responsive element e within the ATP7B promoter and is a strong candidate in regulating the ATP7B expression.
Stalke A; Pfister ED; Baumann U; Illig T; Reischl E; Sandbothe M; Vajen B; Huge N; Schlegelberger B; von Neuhoff N; Skawran B
Ann Hum Genet; 2020 Mar; 84(2):195-200. PubMed ID: 31596515
[TBL] [Abstract][Full Text] [Related]
36. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
37. ATP7B expression confers multidrug resistance through drug sequestration.
Moinuddin FM; Shinsato Y; Komatsu M; Mitsuo R; Minami K; Yamamoto M; Kawahara K; Hirano H; Arita K; Furukawa T
Oncotarget; 2016 Apr; 7(16):22779-90. PubMed ID: 26988911
[TBL] [Abstract][Full Text] [Related]
38. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
[TBL] [Abstract][Full Text] [Related]
39. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
[TBL] [Abstract][Full Text] [Related]
40. YWHA/14-3-3 proteins recognize phosphorylated TFEB by a noncanonical mode for controlling TFEB cytoplasmic localization.
Xu Y; Ren J; He X; Chen H; Wei T; Feng W
Autophagy; 2019 Jun; 15(6):1017-1030. PubMed ID: 30653408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
